Skip to main content

Medication & Treatment

People with diabetes use many medications to both manage blood sugar levels and also to prevent or treat health complications.

For people with type 1 diabetes, the most important drug is insulin; some people with type 2 diabetes also take insulin. For people with type 2 diabetes, glucose-lowering medications include metformin, sulfonylureas, TZDs, SGLT-2 inhibitors, GLP-1 agonists, DPP-4 inhibitors, and more.

Some of these drugs are injected, others are taken in pill form, and some are even inhaled. Learn about the different treatment options available and which might be best for your lifestyle.

Metformin
Insulin
SGLT-2 inhibitors
GLP-1 agonists
DPP-4 inhibitors
Combination drugs
Sulfonylureas (SFUs)
TZDs

What's new

The FDA has announced that 13 companies have voluntarily recalled their extended release metformin due to the possibility that it includes unsafe levels of NDMA, a toxic substance Continue Reading »

InPen – a reusable, Bluetooth-enabled, smart insulin dosing and tracking pen – is now available for people of all ages in the United States Continue Reading »

Lyumjev reduces blood glucose spikes and can be taken at the beginning of a meal, or even 20 minutes into the meal; available through Lilly’s insulin affordability program Continue Reading »

The ready-to-use autoinjector emergency glucagon pen is now available for people over the age of two in the US Continue Reading »

Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications Continue Reading »

The diaTribe team attended the 2020 ADA 80th Scientific Sessions to share several of the greatest highlights from the virtual conference! Continue Reading »

ADA 2020 is officially in the books! Here are some more of our highlights from the last day and a half of ADA’s virtual 80th Scientific Sessions: Teplizumab, Control-IQ, SGLT-2s and GLP-1s, time in range, food as medicine, and more! Continue Reading »

Check out the third day highlights from ADA’s virtual 80th Scientific Sessions – including new insights on off label use in type 1 diabetes, type 2 diabetes remission, DIY closed loop, DSMES, and more! Continue Reading »

Pages